Christopher Stump is a Director, Strategy and Operations, Medical Excellence at Bristol Myers Squibb. He possess expertise in pharmaceutical sales, pharmaceutical industry, cardiology, sales effectiveness, hospital sales and 9 more skills. Colleagues describe him as "Chris has been instrumental leading the sales training efforts in the current US Launch execution of a novel Bayer Pharma hemophilia A Factor VIII therapeutic; Jivi (BAY 94-9027). From my US Launch Leader perspective, we could not have selected a more focused, customer-centric driver of flawless execution. Ask Chris about that Commercial Launch Playbook we co-wrote & executed on. Rarely do you have the Marketing & Sales functions so closely aligned in Launch mode, as we have at Bayer Hematology. Thanks for the partnership, we are going to crush the launch year KPIs. "